Nicholas A. Cacalano

3.4k citations
58 papers · 2.8k indexed · h-index 32

Nicholas A. Cacalano

57 papers receiving 2.7k citations

Peers

Nicholas A. Cacalano
Comparison fields: 5 of 109
  • Immunology 1.4k
  • Oncology 1.3k
  • Cancer Research 414
  • Pharmacology 213
  • Genetics 233
Replace Zhenqiang Yao with:
Zhenqiang Yao United States
Noriko Komatsu Japan
Yasuo Koishihara Japan
Akiko Kukita Japan
Grażyna Hoser Poland
Taeko Yokochi Japan
Kihyuk Shin South Korea
Yoshiyuki Mochida United States
Yoshihiko Sawa Japan
Jean‐Christophe Pagès France
Nicholas A. Cacalano relative to Zhenqiang Yao United States Zhenqiang Yao's profile →
Citations per field
00.5×3.8×
Zhenqiang Yao · 1×
Citations per year

Countries citing papers authored by Nicholas A. Cacalano

Since Specialization
Citations

This map shows the geographic impact of Nicholas A. Cacalano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas A. Cacalano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas A. Cacalano more than expected).

Fields of papers citing papers by Nicholas A. Cacalano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas A. Cacalano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas A. Cacalano. The network helps show where Nicholas A. Cacalano may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Nicholas A. Cacalano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nicholas A. Cacalano Line = papers co-authored together Nicholas A. Cacalano links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201944
2 201918
3 20185
4 201641
5 201460
6 201120
7 201043
8 2010125
9 201065
10 201032
11 200813
12 200825
13 200756
14 200720
15 200710
16 200539
17 200417
18 200396
19 2001175
20 1999213

About Nicholas A. Cacalano

Nicholas A. Cacalano is a scholar working on Immunology, Oncology and Genetics, having authored 58 papers that have together received 2.8k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (18 papers), Cytokine Signaling Pathways and Interactions (17 papers), Mesenchymal stem cell research (7 papers), T-cell and B-cell Immunology (7 papers), NF-κB Signaling Pathways (7 papers), Prostate Cancer Treatment and Research (5 papers), interferon and immune responses (4 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Immunology (1.4k citations), Oncology (1.3k citations) and Cancer Research (414 citations). Nicholas A. Cacalano has collaborated with scholars based in United States, Japan and South Korea. Frequent co-authors include Anahid Jewett, James A. Johnston, Akihiko Yoshimura, Avina Paranjpe, Christian Head, Han-Ching Tseng, Antonia Teruel, Thi Migone, S. Cohney and James A. Johnston. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026